J.M. Lusher

1.1k total citations · 1 hit paper
13 papers, 849 citations indexed

About

J.M. Lusher is a scholar working on Hematology, Immunology and Infectious Diseases. According to data from OpenAlex, J.M. Lusher has authored 13 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 3 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in J.M. Lusher's work include Hemophilia Treatment and Research (8 papers), Blood groups and transfusion (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). J.M. Lusher is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Blood groups and transfusion (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). J.M. Lusher collaborates with scholars based in United States, Italy and Croatia. J.M. Lusher's co-authors include Louis M. Aledort, J. Ingerslev, G C White, C Rothschild, Frits R. Rosendaal, LM Aledort, J. A. Penner, Pascale Levine, GF Gjerset and J. W. Mosley and has published in prestigious journals such as Blood, Vox Sanguinis and Haemophilia.

In The Last Decade

J.M. Lusher

11 papers receiving 818 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.

2001 651 citations G C White, Frits R. Rosendaal et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.M. Lusher United States	8	773	179	152	49	34	13	849
Elena Santagostino Italy	10	498 0.6×	129 0.7×	47 0.3×	67 1.4×	17 0.5×	13	591
Rolf Ljung Sweden	10	302 0.4×	69 0.4×	92 0.6×	36 0.7×	59 1.7×	29	450
JM Boyett United States	12	332 0.4×	108 0.6×	96 0.6×	10 0.2×	44 1.3×	17	657
Rosamaria Rosso Italy	11	150 0.2×	179 1.0×	41 0.3×	22 0.4×	25 0.7×	29	400
J.G. Fuzibet France	9	155 0.2×	61 0.3×	83 0.5×	14 0.3×	26 0.8×	37	341
J. Malcolm United States	5	293 0.4×	188 1.1×	66 0.4×	52 1.1×	67 2.0×	6	409
Suzy Maria Teresa Durazzi Italy	4	413 0.5×	373 2.1×	45 0.3×	39 0.8×	41 1.2×	7	572
G Pizzarelli Italy	9	233 0.3×	298 1.7×	54 0.4×	23 0.5×	16 0.5×	27	402
P Kier Austria	10	184 0.2×	42 0.2×	39 0.3×	23 0.5×	25 0.7×	23	304
Vivian Wu Canada	7	297 0.4×	216 1.2×	60 0.4×	34 0.7×	90 2.6×	12	522

Countries citing papers authored by J.M. Lusher

Since Specialization

Citations

This map shows the geographic impact of J.M. Lusher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Lusher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Lusher more than expected).

Fields of papers citing papers by J.M. Lusher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Lusher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Lusher. The network helps show where J.M. Lusher may publish in the future.

Co-authorship network of co-authors of J.M. Lusher

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Lusher. A scholar is included among the top collaborators of J.M. Lusher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Lusher. J.M. Lusher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Bellissimo, Daniel B., Thomas C. Abshire, W. Keith Hoots, et al.. (2007). Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD).. Blood. 110(11). 709–709. 1 indexed citations

2.

Haberichter, Sandra L., Pamela A. Christopherson, Patricia A. Morateck, et al.. (2007). The Prevalence of Reduced VWF Survival Phenotype (Type 1C VWD) in Type 1 Index Cases Recruited into the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB - VWD).. Blood. 110(11). 2133–2133.

3.

White, G C, Frits R. Rosendaal, Louis M. Aledort, et al.. (2001). Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.. PubMed. 85(3). 560–560. 651 indexed citations breakdown →

4.

Shapiro, Amy D., et al.. (1997). Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures. Haemophilia. 3(4). 247–253. 14 indexed citations

5.

Mannucci, PM, DB Brettler, LM Aledort, et al.. (1994). Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group. Blood. 83(7). 1958–1962. 15 indexed citations

6.

Mosley, J. W., Joseph M. Hassett, GF Gjerset, et al.. (1992). Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group. Blood. 80(3). 831–840. 22 indexed citations

7.

Aledort, Louis M., Margaret W. Hilgartner, Malcolm C. Pike, et al.. (1992). Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.. BMJ. 304(6821). 212–216. 20 indexed citations

8.

Mosley, J. W., Joseph M. Hassett, GF Gjerset, et al.. (1992). Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group. Blood. 80(3). 831–840. 10 indexed citations

9.

Dietrich, Shelby L., J. W. Mosley, J.M. Lusher, et al.. (1990). Transmission of Human Immunodeficiency Virus Type 1 by Dry-Heated Clotting Factor Concentrates(1). Vox Sanguinis. 59(3). 129–135.

10.

Lusher, J.M., M. Elaine Eyster, MW Hilgartner, et al.. (1984). Panel discussion on the treatment of patients with factor VIII inhibitors.. PubMed. 150. 323–35. 6 indexed citations

11.

Lusher, J.M.. (1984). Controlled clinical trials with prothrombin complex concentrates.. PubMed. 150. 277–90. 15 indexed citations

12.

Lusher, J.M., et al.. (1983). Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII. Blood. 62(5). 1135–1138. 2 indexed citations

13.

Lusher, J.M., et al.. (1983). Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII. Blood. 62(5). 1135–1138. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact